77 related articles for article (PubMed ID: 667371)
1. [Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)].
Chauvergne J; Cappelaere P; Carton M; Gary-Bobo J; Klein T
Bull Cancer; 1978; 65(1):19-24. PubMed ID: 667371
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of rubidazone in solid tumors and malignant lymphomas.
Skovsgaard T; Hansen HH; Mouridsen HT; Nissen NI; Pedersen-Bjergaard J
Cancer Treat Rep; 1978 Jul; 62(7):1053-8. PubMed ID: 356967
[TBL] [Abstract][Full Text] [Related]
3. [Anticancerous chemotherapy trial with duborimycin. Analysis of 151 cases].
Chauvergne J; Carton M; Berlie J; Brulé G; Clavel B; Gary-Bobo J; Guerrin J; Klein T; Pommatau E
Bull Cancer; 1976; 63(1):41-58. PubMed ID: 990509
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
[TBL] [Abstract][Full Text] [Related]
6. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
Zidar BL; Benjamin RS; Frank J; Lane M; Baker LH
Am J Clin Oncol; 1983 Feb; 6(1):71-4. PubMed ID: 6837508
[TBL] [Abstract][Full Text] [Related]
8. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
[TBL] [Abstract][Full Text] [Related]
9. [Survey of anthracyclines derivatives in haematology (author's transl)].
Jacquillat C; Weil M; Auclerc MF; Maral J; Schaison G; Boiron M; Bernard J
Nouv Presse Med; 1978 Jun; 7(23):2061-6. PubMed ID: 673774
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P; Cappelaere P; Armand JP; Mathé G
Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Rose PG; Blessing JA; Lele S; Abulafia O
Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
Bastholt L; Dalmark M
Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
Kovach JS; Ames MM; Sternad ML; O'Connell MJ
Cancer Res; 1979 Mar; 39(3):823-8. PubMed ID: 427770
[TBL] [Abstract][Full Text] [Related]
16. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
17. [Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
Korman DB; Mikaélian SG; Boronovskaia LE; Maslova IA
Vopr Onkol; 2004; 50(2):202-7. PubMed ID: 15176224
[TBL] [Abstract][Full Text] [Related]
18. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
Jelić S; Tomasević Z; Kreacić M; Kovcin V; Radosavljević D; Vlajić M
Bull Cancer; 1996 Dec; 83(12):1002-7. PubMed ID: 9116363
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
20. [The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients].
Medvedev PV; Nikitin EA; Pivnik AV
Ter Arkh; 2000; 72(7):38-42. PubMed ID: 10983319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
